Assignee
VIVERA PHARMACEUTICALS INC
US·5 granted patents·11 pending applications·12 citations·filing 2018–2022
Top patents by PatentIndex Score
16 records- 0190US11594149B1Speech fluency evaluation and feedbackVIVERA PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·6 cites·20 claims
- 0282US11450420B2Secure smart dosing system with automated delivery, measurement, and management for pillsVIVERA PHARMACEUTICALS INC·Filed 2021·Granted Sep 20, 2022·1 cites·17 claims
- 0376US11090449B2Smart inhaler device with automated dose delivery, measurement, and managementVIVERA PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·3 cites·8 claims
- 0473US11083850B2Secure smart dosing system with automated delivery, measurement, and managementVIVERA PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·2 cites·15 claims
- 0572US2022062189A1Sublingual Delivery for Mitigation of Side Effects Associated with Sildenafil CitrateVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0671US2021401757A1Sublingual delivery for mitigation of side effects associated with olanzapine and metforminVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0771US2021401758A1Sublingual delivery for mitigation of side effects associated with trazodoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0870US2023104820A1Self-Contained, Portable, Sanitization Device and Telemedicine StationVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0965US11406728B2Self-contained, portable, sanitization device and telemedicine stationVIVERA PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·0 cites·7 claims
- 1054US2023114360A1Sublingual Delivery for Mitigation of Side Effects Associated with ZicronapineVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1152US2022023223A1Sublingual delivery for mitigation of side effects associated with blonanserinVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1250US2022168226A1Sublingual delivery for mitigation of side effects associated with metforminVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1350US2022117900A1Sublingual delivery for mitigation of side effects associated with vortioxetineVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1450US2022096387A1Sublingual delivery for mitigation of side effects associated with lurasidoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1550US2022117901A1Sublingual delivery for mitigation of side effects associated with brexpiprazoleVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1648US2021311056A1Self-administered infection testing and result determinationVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIVERA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →